Reactive Angioendotheliomatosis by Gupta, Naeha, DO et al.





Lehigh Valley Health Network, Naeha.Gupta@lvhn.org
Richard McCalin MD
Lehigh Valley Health Network, Richard_W.Mcclain@lvhn.org
Nektarios I. Lountzis MD
Lehigh Valley Health Network, nektarios_i.lountzis@lvhn.org
Follow this and additional works at: https://scholarlyworks.lvhn.org/medicine
Part of the Dermatology Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Gupta, N. McCalin, R. Lountzis, N. (2019, March 22). Reactive Angioendotheliomatosis. poster Presented at: Philadelphia
Dermatological Society, Philadelphia, PA.
LVHN.org
© 2019 Lehigh Valley Health Network
Reactive Angioendotheliomatosis 
Naeha Gupta, DO, Richard McClain, MD, and Nektarios Lountzis, MD
Lehigh Valley Health Network, Allentown, PA
HISTORY OF PRESENT ILLNESS: 60 year-old Caucasian male presents 
with a lesion on his left thigh for three months. The lesion is initially a pink plaque 
described to be the size of a lemon with subsequent progression in size, pain and 
central crusting. He has no history of similar lesions elsewhere. Patient was 
recently evaluated by vascular surgery and was found to have stenosis as well as 
occlusion of the left iliac arteries via ultrasound. He is also noted to have had a 
stroke, myocardial infarction, and pancreatitis within the last three months.
MEDICAL HISTORY/SURGICAL HISTORY: Deep venous thrombosis of 
left distal lower extremity, cholecystectomy, colonoscopy, stroke, hyperlipidemia, 
hypertension, myocardial infarction, and pancreatitis
MEDICATIONS: Atorvastatin, duloxetine, levothyroxine, trazodone, clopidogrel, 
metoprolol, oxycodone-acetaminophen
PREVIOUS TREATMENTS: Triamcinolone 0.1% ointment twice daily as 
needed
CURRENT TREATMENT: Left common femoral endarectomy with bovine 
patch per vascular surgery, local wound care
PHYSICAL EXAMINATION: Pink to red large plaque on the left medial 
thigh with a small amount of scale. More centrally, there is firm white induration  
of the plaque with dark brown scale crust. The right leg is clear.
LABORATORY DATA: Hemoglobin 11.7 g/dL (12.0-17.0), platelets 418 
thousand s/uL (149-390), fibrinogen 503 mg/dL (227-495), and erythrocyte 
sedimentation rate 36 mm/hr (0-11)
STUDIES: Vascular study of abdominal aorta and iliac arteries reveals aorta to 
be patent and normal in caliber with mild diffuse arterial occlusive disease noted, 
elevate velocities suggest a 50 to 75% stenosis in the mid right external iliac 
artery with stent, high grade stenosis versus occlusion of the left iliac artery with 
reconstitution of the distal external iliac artery.
BIOPSY: Cleveland Clinic (S18-27479, 2/27/2018) Left thigh: “poorly-
demarcated dermal-based proliferation of poorly formed slit like vascular spaces 
which percolate through reticular collagen bundles, surround adnexal structures 
and extend into the subcutis. The vascular spaces are lined with flattened, bland 
endothelial cells without cytologic atypia or mitotic activity. CD31 and 34 stains 
reveal a patchy proliferation of capillaries scattered throughout the dermis. HHV8 
stain, to rule out Kaposi ’s sarcoma, is negative.”
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Reactive Angioendotheliomatosis (RAE) is a rare, benign condition that presents 
with a cutaneous vascular proliferation with secondary intravascular thrombi 
leading to necrosis and infarction of the skin. RAE tends to occur in patients with 
coexistent systemic diseases. Clinical presentation demonstrates erythematous 
macules, purpuric papules, and purpuric plaques, which can be ulcerated. Lesions 
can affect the face or trunk, but tend to target the limbs. The condition favors 
middle-aged adults with no gender predilection. Patients may experience 
constitutional symptoms, such as fevers and weight loss. Many patients also have 
an elevated erythrocyte sedimentation rate. Other laboratory abnormalities can 
include thrombocytopenia, anemia, and leukocytosis. Coexistent diseases are 
broad in the literature and include infectious diseases, systemic disease, blood 
disorders, monoclonal gammopathies, and vascular abnormalities, including severe 
peripheral vascular atherosclerotic disease. 
While the pathogenesis is unknown, changes in portal and systemic 
hemodynamics as well as a response to local hypoxia have been reported. This is 
further supported by the cases of RAE that improve after arterial bypass 
procedures, corroborating the notion that local tissue hypoxia may have been an 
inciting agent leading to induction of angiogenesis. Another theory is that deposition 
of complement and immunoglobulins may induce vascular injury. Furthermore, 
association with underlying systemic infections suggest that RAE can represent a 
hypersensitivy response of endothelial cells to foreign antigens. This 
hypersensitivity response leads to deposition of immunoglobulins in capillaries in the 
skin leading to thrombi and ensuing local hypoxia.
On histopathology, the individual lesions can vary. Histopathologic examination 
shows dilated vessels in the dermis and upper subcutaneous fat, filled with cells 
and fibrin, sometimes leading to vascular occlusion. There may be proliferation of 
pericytic myoepithelial cells. The intravascular cells are positive for CD31, and  
CD34 but negative for HHV-8. In addition, intravascular cells will be positive for  
Ulex Europeus and factor VIII-associated antigen supporting an endothelial origin. 
Other important clinical entities to consider include Kaposi’s Sarcoma and 
angiosarcoma. Prognosis of RAE is generally good and characterized by  
self-limited disease. Therapy, if needed, is directed at the underlying systemic 
disease. However, no specific treatment is currently available. Consideration  
can be made for antibiotics for infections and systemic steroids for their  
suppressive role on neoangiogenesis when no apparent cause can be found.  
In all, RAE is a rare disease related to a reactive endothelial proliferation in  
response to an unknown stimulus.
Figure B. H&E at 4x. Dermal based proliferation of spindle cells.
Figure C. H&E at 20x. Flattened endothelial cells without 
cytologic atypia or mitotic activity.
Figure A. Clinical presentation of left thigh. 
Figure D. CD34 stain showing patchy proliferation of capillaries 
throughout the dermis.
